Novavax
NVAX
#5751
Rank
A$1.69 B
Marketcap
A$10.40
Share price
0.73%
Change (1 day)
-19.16%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of September 2025 : A$1.77 Billion

According to Novavax's latest financial reports the company's total assets are A$1.77 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$2.50 B-4.91%
2023-12-31A$2.63 B-20.51%
2022-12-31A$3.31 B-6.61%
2021-12-31A$3.55 B72.7%
2020-12-31A$2.05 B733.1%
2019-12-31A$0.24 B-16.32%
2018-12-31A$0.29 B-23.81%
2017-12-31A$0.38 B-29.17%
2016-12-31A$0.54 B3.23%
2015-12-31A$0.52 B57.13%
2014-12-31A$0.33 B27.94%
2013-12-31A$0.26 B167.65%
2012-12-31A$98.48 M51.68%
2011-12-31A$64.93 M-11.88%
2010-12-31A$73.68 M-22.68%
2009-12-31A$95.29 M-12.26%
2008-12-31A$0.10 B4.01%
2007-12-31A$0.10 B-32.46%
2006-12-31A$0.15 B34.06%
2005-12-31A$0.11 B14.42%
2004-12-31A$0.10 B-10.99%
2003-12-31A$0.11 B10.93%
2002-12-31A$0.10 B-22.39%
2001-12-31A$0.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
A$0.35 B-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$5.25 B 196.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.19 B 23.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.67 B-62.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$172.31 B 9,600.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$314.24 B 17,590.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$161.52 B 8,993.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
A$13.28 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.14 B 6,888.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
A$0.97 B-45.04%๐Ÿ‡บ๐Ÿ‡ธ USA